Evaluation Model Used: gpt-5
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Epoch: 5.0
	Rank: 16
	QLoRA Alpha: 16.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with neonatal morbidity and is a better measure of undernutrition in neonates than birth weight percentiles. The use of BF% as a measure of undernutrition in neonates may be more useful in identifying those at risk of serious morbidity than birth weight percentiles alone. The association between BF% and neonatal morbidity is more robust than that between birth weight percentile and neonatal morbidity. These data support the use of BF% as a screening tool for undernutrition in neonates. Further work is required to determine whether BF% is a better measure of undernutrition than other anthropometric measures and to determine the best method for measuring BF%. Future studies should also assess the clinical and economic implications of using BF% as a screening tool for undernutrition in neonates.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 1.0
Reasoning:
The assistant’s response aligns with the study’s findings: it correctly states that body fat percentage is more strongly associated with neonatal morbidity than birth weight percentiles and supports its use as a screening tool for undernutrition. While it doesn’t include specific statistics, its conclusions are consistent with the ground truth and do not introduce inaccuracies.

conciseness: 0.4
Reasoning:
The response answers the yes/no question correctly and clearly, but it is repetitive and includes extraneous statements about future research and other measures that are not necessary for a concise reply. It could have been a single succinct sentence.

relevance: 0.6
Reasoning:
The assistant’s response is relevant and directly answers “yes,” aligning with the context that BF% is more strongly associated with neonatal morbidity than birth weight percentiles. However, it does not reference or quote specific evidence from the provided context (e.g., the ORs or the explicit statement that BF% is more closely associated), which the evaluation prioritizes. It also adds speculative recommendations beyond the context.

coherence: 0.9
Reasoning:
The response directly answers the question, maintains a clear and consistent stance that BF% is a better measure than birth weight percentiles, and supports this with a coherent explanation that BF% shows a stronger association with neonatal morbidity. It is organized, flows logically from conclusion to rationale, and adds reasonable context about implications and future work. There is minor repetition, but overall the structure is clear and coherent.

helpfulness: 0.9
Reasoning:
The response directly answers the question with a clear “yes,” aligns with the study’s findings that BF% is more strongly associated with neonatal morbidity than birth weight percentiles, and notes its value as a screening tool. It is generally helpful and appropriate. However, it could be improved by explicitly mentioning the added clinical utility highlighted in the ground truth (identifying appropriately grown but undernourished neonates and excluding small neonates not at risk) and by briefly referencing the comparative strength of associations (e.g., higher OR for BF%).

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The healing time of the lesions is comparable to the results of previous studies of Charcot foot, which also showed a mean healing time of around 200 days. In contrast to other studies, the present study did not show a significant difference between the treatment of ischemic and non-ischemic Charcot foot, but the small sample size may have limited the power to detect differences. The treatment of ischemic Charcot foot with endovascular revascularization, surgical debridement and orthopedic correction seems to be safe and effective. Further studies are needed to confirm the results.
The limb salvage rate was 90% in our study, which is comparable to other studies. The results suggest that endovascular revascularization, surgical debridement and orthopedic correction can be performed safely and effectively in patients affected by ischemic Charcot neuroarthropathy, even if the lesions are extensive. The combination of surgical and orthopedic treatment seems to be effective to avoid major amputation in patients affected by ischemic Charcot neuroarthropathy.
The results of this study should be confirmed in a larger series of patients. Future studies should also evaluate the long-term results of treatment of ischemic Charcot neuroarthropathy, to assess the need for re-interventions and to verify the efficacy of the treatment. The combination of endovascular and surgical treatment could be an alternative to the treatment of non-ischemic Charcot foot.
The results of this study suggest that the treatment of ischemic Charcot neuroarthropathy can be performed with a combination of endovascular revascularization, surgical debridement and orthopedic correction. Further studies are needed to confirm these results and to evaluate the long-term results of treatment of ischemic Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.4
Reasoning:
The answer includes some correct details from the study (90% limb salvage, mean healing time around 197 days, and the use of endovascular revascularization plus surgical/orthopedic treatment). However, it makes unsupported claims about comparisons with non-ischemic Charcot foot and significance testing, which are not in the provided context. It also fails to directly address the central implication of the question—that ischemic Charcot foot requires a different approach with necessary revascularization to support surgery and avoid amputation.

conciseness: 0.3
Reasoning:
The answer is verbose and repetitive, with multiple paragraphs reiterating the same points and adding extraneous comments about future studies. It does not directly and concisely address the core question of whether ischemic Charcot foot requires a different treatment approach. A concise answer would state that in ischemic Charcot foot, revascularization is necessary alongside surgical and orthopedic management to avoid amputation and achieve limb salvage.

relevance: 0.5
Reasoning:
The response is partly relevant: it mentions endovascular revascularization with surgical and orthopedic treatment, cites correct figures from the context (90% limb salvage; mean healing time ~197 days), and discusses safety/effectiveness. However, it does not directly address the central takeaway that revascularization is necessary to support limb salvage in ischemic Charcot foot. It also introduces unsupported claims (e.g., no significant difference vs. non-ischemic cases, comparability to other studies) and does not provide a direct quote from the context.

coherence: 0.5
Reasoning:
The response is generally coherent and readable, summarizing outcomes (90% limb salvage, ~200-day healing) and describing the treatment approach. However, it does not directly answer the question of whether ischemic Charcot foot represents a different disease needing different treatment; instead it hedges with comparisons to non-ischemic cases and repeats calls for further studies. The structure is somewhat repetitive and lacks a clear, concise stance aligned with the context.

helpfulness: 0.5
Reasoning:
The response summarizes outcomes (≈200-day healing time, 90% limb salvage) and notes that endovascular revascularization plus surgical/orthopedic management appears safe and effective. However, it does not directly address the question of whether ischemic Charcot foot is a “different disease with different treatment,” and it introduces potentially misleading statements about no significant differences versus non-ischemic cases. It also fails to emphasize that revascularization is necessary to support surgical/orthopedic care to avoid amputation, which is the key takeaway.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Radical hysterectomy is recommended for patients with endometrial adenocarcinoma and suspected gross cervical involvement. However, the efficacy of this procedure has not been confirmed. In this study, we retrospectively analyzed 300 patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions. The results showed that type of hysterectomy was not an independent prognostic factor for local recurrence-free survival, PFS, or OS. However, RH was associated with longer operative time and higher rates of blood transfusion and severe urinary tract dysfunction. Although RH is recommended for patients with suspected gross cervical involvement, this study suggests that mRH and SH may be reasonable alternatives. Patients should be discussed with the attending physician and the choice of surgical procedure should be based on the individual patient's condition.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.9
Reasoning:
The assistant’s answer accurately reflects the study’s findings: the type of hysterectomy was not an independent prognostic factor for survival outcomes, and radical hysterectomy was associated with more operative morbidity (longer operative time, higher transfusion rates, urinary dysfunction). It appropriately infers that RH may not be necessary and that less radical procedures could be reasonable alternatives. A minor omission is the explicit statement that no survival benefit from RH was found and the call for prospective studies, but the core conclusions are correctly conveyed.

conciseness: 0.7
Reasoning:
The response conveys the key takeaway that the type of hysterectomy was not a prognostic factor and notes higher morbidity with radical hysterectomy, which addresses the question. However, it includes redundant background, specific study details (years, institutions, sample size) that are not essential for a concise answer, and adds generic advice to consult a physician. It also omits the explicit “no survival benefit” phrasing and the call for prospective studies, which could have been stated succinctly.

relevance: 0.9
Reasoning:
The response is highly relevant and accurately reflects the context: it states that the type of hysterectomy was not an independent prognostic factor for OS/PFS and that RH had more perioperative morbidity (longer operative time, higher transfusion rates, urinary dysfunction), aligning with the study’s findings. It answers the core question by implying RH may not be necessary and that less radical procedures could be reasonable. Minor issues: it uses first-person “we” and does not explicitly mention the absence of survival benefit or the call for prospective studies, and it does not include a direct quote from the context.

coherence: 0.9
Reasoning:
The response is coherent and well-structured. It summarizes the study design and findings, directly addressing whether radical hysterectomy is needed by noting that hysterectomy type was not an independent prognostic factor for survival outcomes and that RH had more operative morbidity. It maintains logical flow from background to methods to conclusions. While it could be slightly more explicit in stating "no survival benefit from RH," the implication is clear. Overall, it answers the question coherently.

helpfulness: 0.9
Reasoning:
The assistant’s answer accurately summarizes the study’s key findings: the type of hysterectomy was not an independent prognostic factor for survival outcomes, and radical hysterectomy was associated with more operative morbidity (longer operative time, higher transfusion rates, urinary dysfunction). It appropriately suggests that mRH or SH may be reasonable alternatives and emphasizes individualized decision-making. It could be slightly improved by explicitly stating that no survival benefit from RH was found and by noting the call for prospective studies, but overall it is clear, aligned with the context, and helpful.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD can be predicted by several preoperative variables. The readmission rate is higher in the second half of the decade. The most common reasons for immediate readmissions are gastrointestinal complications, whereas late readmissions are due to infectious complications. The reasons for readmissions can be prevented by optimizing perioperative care. We recommend the following: (1) preoperative optimization of gastrointestinal function, (2) meticulous surgical technique, (3) adequate postoperative fluid resuscitation, (4) early postoperative nutritional support, (5) prompt treatment of any complications, (6) minimizing the length of initial hospital stay, and (7) early discharge of patients who do not require further hospitalization. Proper postoperative care and close follow-up may reduce the rate of readmissions.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.2
Reasoning:
The response omits key findings and introduces inaccuracies. It fails to identify the independent predictors of readmission shown by the study (pancreatic fistula and complexity/multivisceral resection, as well as longer initial LOS and ICU admission) and instead vaguely attributes prediction to “preoperative variables.” It oversimplifies reasons for early vs late readmissions, labeling late readmissions as primarily infectious when the study reports mixed causes (including failure to thrive and hemorrhage). It also provides speculative recommendations (e.g., minimizing LOS and early discharge) not supported by the data and contrary to the association of longer LOS with readmissions. Crucially, it does not emphasize that half of readmissions occur within 7 days and that prevention efforts should focus on early readmissions.

conciseness: 0.3
Reasoning:
The response is generic and not concise. It inaccurately states that preoperative variables predict readmissions, omitting the key independent factors (pancreatic fistula and multivisceral resection). It also fails to emphasize that half of readmissions occur within 7 days and that efforts should focus on preventing early readmissions. The prevention recommendations are vague and partly contradictory (e.g., minimizing length of stay vs. early discharge) and not directly grounded in the provided data.

relevance: 0.3
Reasoning:
The response is only partially relevant to the context. It notes that readmission rates were higher in the second half of the decade, which aligns with the context, and it distinguishes early versus late readmission causes, though in an oversimplified and partly inaccurate way. However, it fails to reference key findings from the context: it does not mention that pancreatic fistula and the complexity of the initial resection (multivisceral resection) were independently associated with readmissions, nor that half of readmissions occurred within 7 days and efforts should focus on preventing early readmissions. It also introduces unsupported claims (e.g., “preoperative variables”) and suggests strategies like minimizing length of stay/early discharge that are not substantiated by the context. No direct quotes are provided.

coherence: 0.3
Reasoning:
The response is organized and attempts to address prevention, but it lacks coherence with the provided evidence. It incorrectly attributes prediction to “preoperative variables,” omits the key independent predictors (pancreatic fistula and multivisceral/multivisceral resection complexity), and does not emphasize preventing early readmissions, which constitute half. The proposed prevention measures are generic and partly contradictory (e.g., advocating shorter initial stays) and are not clearly tied to the study’s findings.

helpfulness: 0.3
Reasoning:
The response is generic and misses key findings from the study. It incorrectly claims prediction by “preoperative variables” and fails to identify the specific independent predictors (pancreatic fistula and complexity/multivisceral resection, as well as ICU stay and longer initial LOS). It oversimplifies reasons for early vs late readmissions and does not emphasize that half of readmissions occur within 7 days, where prevention efforts should focus. Some recommendations are vague or potentially counterproductive (e.g., promoting early discharge without acknowledging the high rate of early readmissions). Overall, it provides limited, partially inaccurate guidance.

================================================================================
Average correctness Score: 0.52
Average conciseness Score: 0.375
Average relevance Score: 0.505
Average coherence Score: 0.55
Average helpfulness Score: 0.52
